Clene is clinical-stage biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative diseases to restore and protect neuronal health and function. Our nanotherapeutic platform is produced utilizing a patented electro-crystal-chemistry process that results in highly-faceted, clean-surfaced nanocrystals of pure transition elements. This innovative platform can be applied to developing a wide range of nanotherapeutics with unique energy profiles, generating a pipeline of drug candidates with broad applicability across different diseases. Founded in 2013, the company is based in Salt Lake City, Utah with R&D and manufacturing operations located in North East, Maryland. For more information, please visit www.clene.com. This is an exciting time for us. We have been receiving many requests for more information. We hope you understand we cannot respond to individual requests. We instead invite you to visit our website, read our press releases, and check back for updates. For more information, please visit www.clene.com.